Cancer reversion, a renewed challenge in systems biology

de Magalhaes, 2013, How ageing processes influence cancer, Nat Rev Cancer, 13, 357, 10.1038/nrc3497 Holohan, 2013, Cancer drug resistance: an evolving paradigm, Nat Rev Cancer, 13, 714, 10.1038/nrc3599 Restifo, 2016, Acquired resistance to immunotherapy and future challenges, Nat Rev Cancer, 16, 121, 10.1038/nrc.2016.2 Powers, 2016, Inducing stable reversion to achieve cancer control, Nat Rev Cancer, 16, 266, 10.1038/nrc.2016.12 Telerman, 2009, The molecular programme of tumour reversion: the steps beyond malignant transformation, Nat Rev Cancer, 9, 206, 10.1038/nrc2589 Creixell, 2012, Navigating cancer network attractors for tumor-specific therapy, Nat Biotechnol, 30, 842, 10.1038/nbt.2345 Askanazy, 1907, Die Teratome nach ihrem Bau, ihrem Verlauf, ihrer Genese und im Vergleich zum experimentellen Teratoid, Verhandl Dtsch Gesellsch Pathol, 11, 39 Braun, 1951, Recovery of tumor cells from effects of the tumor-inducing principle in crown gall, Science, 113, 651, 10.1126/science.113.2945.651.b Macpherson, 1965, Reversion in hamster cells transformed by rous sarcoma virus, Science, 148, 1731, 10.1126/science.148.3678.1731 Pollack, 1968, Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability, Proc Natl Acad Sci U S A, 60, 126, 10.1073/pnas.60.1.126 DeCosse, 1973, Breast cancer: induction of differentiation by embryonic tissue, Science, 181, 1057, 10.1126/science.181.4104.1057 Mintz, 1975, Normal genetically mosaic mice produced from malignant teratocarcinoma cells, Proc Natl Acad Sci U S A, 72, 3585, 10.1073/pnas.72.9.3585 Weaver, 1997, Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies, J Cell Biol, 137, 231, 10.1083/jcb.137.1.231 McCullough, 1998, Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors, Proc Natl Acad Sci U S A, 95, 15333, 10.1073/pnas.95.26.15333 Postovit, 2008, Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells, Proc Natl Acad Sci U S A, 105, 4329, 10.1073/pnas.0800467105 Huang, 1988, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, 567, 10.1182/blood.V72.2.567.567 Sarraf, 1998, Differentiation and reversal of malignant changes in colon cancer through PPARgamma, Nat Med, 4, 1046, 10.1038/2030 Munster, 2001, The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells, Cancer Res, 61, 8492 Felsher, 1999, Reversible tumorigenesis by MYC in hematopoietic lineages, Mol Cell, 4, 199, 10.1016/S1097-2765(00)80367-6 Weinstein, 2000, Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis, Carcinogenesis, 21, 857, 10.1093/carcin/21.5.857 Huettner, 2000, Reversibility of acute B-cell leukaemia induced by BCR-ABL1, Nat Genet, 24, 57, 10.1038/71691 Sansom, 2007, Myc deletion rescues Apc deficiency in the small intestine, Nature, 446, 676, 10.1038/nature05674 Dow, 2015, Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer, Cell, 161, 1539, 10.1016/j.cell.2015.05.033 Hochedlinger, 2004, Reprogramming of a melanoma genome by nuclear transplantation, Genes Dev, 18, 1875, 10.1101/gad.1213504 Miyoshi, 2010, Defined factors induce reprogramming of gastrointestinal cancer cells, Proc Natl Acad Sci U S A, 107, 40, 10.1073/pnas.0912407107 Stricker, 2013, Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner, Genes Dev, 27, 654, 10.1101/gad.212662.112 McClellan, 2015, Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages, Proc Natl Acad Sci U S A, 112, 4074, 10.1073/pnas.1413383112 Kitayama, 1989, A ras-related gene with transformation suppressor activity, Cell, 56, 77, 10.1016/0092-8674(89)90985-9 Telerman, 1993, A model for tumor suppression using H-1 parvovirus, Proc Natl Acad Sci U S A, 90, 8702, 10.1073/pnas.90.18.8702 Tuynder, 2002, Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1, Proc Natl Acad Sci U S A, 99, 14976, 10.1073/pnas.222470799 Seilern-Aspang, 1962, Induction and differentiation of an epithelial tumour in the newt (Triturus cristatus), J Embryol Exp Morphol, 10, 337 Bloch-Shtacher, 1972, Chromosomal mechanism for the induction of reversion in transformed cells, Int J Cancer, 9, 632, 10.1002/ijc.2910090321 Fischinger, 1972, Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus, Science, 176, 1033, 10.1126/science.176.4038.1033 Hendrix, 2007, Reprogramming metastatic tumour cells with embryonic microenvironments, Nat Rev Cancer, 7, 246, 10.1038/nrc2108 Topczewska, 2006, Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness, Nat Med, 12, 925, 10.1038/nm1448 Meng-er, 1988, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, 567, 10.1182/blood.V72.2.567.567 Zheng, 2005, Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation apoptosis of promyelocytic leukemia, Proc Natl Acad Sci U S A, 102, 7653, 10.1073/pnas.0502825102 Pelengaris, 2002, c-MYC: more than just a matter of life and death, Nat Rev Cancer, 2, 764, 10.1038/nrc904 Fehrenbach, 2016, Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage, Sci Rep, 6, 28891, 10.1038/srep28891 Zhang, 2013, Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming, Oncogene, 32, 2249, 10.1038/onc.2012.237 Xu, 2007, Histone deacetylase inhibitors: molecular mechanisms of action, Oncogene, 26, 5541, 10.1038/sj.onc.1210620 Wakefield, 2013, Beyond TGFβ: roles of other TGFβ superfamily members in cancer, Nat Rev Cancer, 13, 328, 10.1038/nrc3500 Barabási, 2004, Network biology: understanding the cell's functional organization, Nat Rev Genet, 5, 101, 10.1038/nrg1272 Carro, 2010, The transcriptional network for mesenchymal transformation of brain tumours, Nature, 463, 318, 10.1038/nature08712 Suva, 2014, Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells, Cell, 157, 580, 10.1016/j.cell.2014.02.030 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Cahan, 2014, CellNet: network biology applied to stem cell engineering, Cell, 158, 903, 10.1016/j.cell.2014.07.020 D'Alessio, 2015, A systematic approach to identify candidate transcription factors that control cell identity, Stem Cell Rep, 5, 763, 10.1016/j.stemcr.2015.09.016 Rackham, 2016, A predictive computational framework for direct reprogramming between human cell types, Nat Genet, 48, 331, 10.1038/ng.3487 Chan, 2013, What is a master regulator?, J Stem Cell Res Ther, 3 Chen, 2014, Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks, Cell, 159, 402, 10.1016/j.cell.2014.09.021 Basso, 2005, Reverse engineering of regulatory networks in human B cells, Nat Genet, 37, 382, 10.1038/ng1532 Yugi, 2014, Reconstruction of insulin signal flow from phosphoproteome and metabolome data, Cell Rep, 8, 1171, 10.1016/j.celrep.2014.07.021 Varemo, 2015, Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes, Cell Rep, 11, 921, 10.1016/j.celrep.2015.04.010 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 El Snoussi, 1993, Logical identification of all steady states: the concept of feedback loop characteristic states, Bull Math Biol, 55, 973, 10.1016/S0092-8240(05)80199-5 Thomas, 1995, Dynamical behaviour of biological regulatory networks-I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state, Bull Math Biol, 57, 247, 10.1007/BF02460618 Choi, 2012, Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damage, Sci Signal, 5, 10.1126/scisignal.2003363 Fumia, 2013, Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes, PLoS One, 8, e69008, 10.1371/journal.pone.0069008 Grieco, 2013, Integrative modelling of the influence of MAPK network on cancer cell fate decision, PLoS Comput Biol, 9, e1003286, 10.1371/journal.pcbi.1003286 Chu, 2015, Precritical state transition dynamics in the attractor landscape of a molecular interaction network underlying colorectal tumorigenesis, PLoS One, 10, e0140172, 10.1371/journal.pone.0140172 Saez-Rodriguez, 2015, Modeling signaling networks to advance new cancer therapies, Annu Rev Biomed Eng, 17, 143, 10.1146/annurev-bioeng-071813-104927 Fujii, 2016, A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis, Cell Stem Cell, 18, 827, 10.1016/j.stem.2016.04.003 Cho, 2016, Attractor landscape analysis of colorectal tumorigenesis and its reversion, BMC Syst Biol, 10, 96, 10.1186/s12918-016-0341-9 Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 Omberg, 2013, Enabling transparent and collaborative computational analysis of 12 tumor types within the Cancer Genome Atlas, Nat Genet, 45, 1121, 10.1038/ng.2761 Liu, 2016, Control principles of complex systems, Rev Mod Phys, 88, 035006, 10.1103/RevModPhys.88.035006 Liu, 2011, Controllability of complex networks, Nature, 473, 167, 10.1038/nature10011 Cornelius, 2013, Realistic control of network dynamics, Nat Commun, 4, 1942, 10.1038/ncomms2939 Wang, 2016, A geometrical approach to control and controllability of nonlinear dynamical networks, Nat Commun, 7, 11323, 10.1038/ncomms11323 Kim, 2013, Discovery of a kernel for controlling biomolecular regulatory networks, Sci Rep, 3, 2223, 10.1038/srep02223 Cho, 2016, The reverse control of irreversible biological processes, Wiley Interdiscip Rev Syst Biol Med, 8, 366, 10.1002/wsbm.1346 Lu, 2015, Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets, Sci Rep, 5, 10.1038/srep14739 Altrock, 2015, The mathematics of cancer: integrating quantitative models, Nat Rev Cancer, 15, 730, 10.1038/nrc4029 Nacher, 2015, Structurally robust control of complex networks, Phys Rev E Stat Nonlin Soft Matter Phys, 91, 012826, 10.1103/PhysRevE.91.012826